NL-OMON28791已完成1 期
Autologous dendritic cells loaded with allogenic tumor lysate for surgically resected pancreatic cancer patients
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
研究者
相似试验
撤回
2 期
Autologous Dendritic Cells Loaded with Allogenic Tumor Lysate for Surgically Resected Pancreatic Cancer Patients (REACtiVe trial).pancreatic cancerNL-OMON46414Erasmus MC, Universitair Medisch Centrum Rotterdam10
撤回
2 期
Autologous Dendritic Cells Loaded with Allogenic Tumor Lysate for Surgically Resected Pancreatic Cancer Patients (REACtiVe Trial)pancreatic cancerNL-OMON44379Erasmus MC, Universitair Medisch Centrum Rotterdam10
已完成
2 期
Autologous Dendritic Cells Loaded with Allogenic Tumor Lysate for Surgically Resected Pancreatic Cancer Patients (REACtiVe trial).pancreatic cancerNL-OMON52670Erasmus MC, Universitair Medisch Centrum Rotterdam38
撤回
2 期
Autologous Dendritic Cells Loaded with Allogenic Tumor Lysate for Surgically Resected Pancreatic Cancer Patients (REACtiVe Trial)<br>pancreatic cancerNL-OMON45421Stichting Leveronderzoek26
已完成
不适用
Dendritic Cells loaded with allogeneic tumor lysate (MesoPher) in combination with a CD40 agonist (Mitazalimab) in metastatic pancreatic disease (REACtiVe-2 Trial)NL-OMON52234Erasmus MC, Universitair Medisch Centrum Rotterdam30
